Carbonic anhydrase IX-targeted small molecule radiopharmaceuticals: A review of their role in clear cell renal cell carcinoma theranostics
{{output}}
Background: Clear cell renal cell carcinoma (ccRCC) is the most common renal cancer subtype, representing 70-80% of cases. Its unique molecular profile and therapeutic resistance make it a key focus in oncology. Recent advances i... ...
